INVA

Latest SEC Filings & News for INVA

1 most recent filing and news item mentioning INVA. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/INVA/news?limit=20"

Pull INVA filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

EarningsAug 5, 2026Neutral

Innoviva Q2 2026 revenue up 19%

Innoviva reported Q2 2026 revenue of $119.6 million, increasing 19% year-over-year, driven by its royalty portfolio and net product sales growth from its IST platform. The company also launched Nortiva Bio and announced a licensing agreement with Dr. Reddy's Laboratories.

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.